FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3082644037> ?p ?o ?g. }

• W3082644037 abstract "We have identified a distinct role for the immunoregulatory, tryptophan-catabolizing enzyme IDO1 (indoleamine 2,3-dioxygenase) in supporting neovascularization through its positioning as a key regulatory node between the inflammatory cytokines IFNγ (interferon γ) and IL6 (interleukin 6). IFNγ is a primary inducer of IDO1, but is also a key mediator of immune-based tumor suppression, which some studies have associated with its anti-angiogenic activity. Conversely, genetic studies in mice have clearly established a tumor-promoting role for IDO1, suggesting that it may interact with IFNγ in a negative feedback capacity. Targeted disruption of the Ido1 gene in mice resulted in enhanced resistance to lung tumor and metastasis development. This corresponded with attenuated induction of the pro-angiogenic cytokine IL6, which, when provided through ectopic expression, was able to restore pulmonary metastasis susceptibility to Ido1-/- mice. These initial findings suggested that IDO1 might contribute to cancer promotion by countering the anti-neovascular effect of IFNγ, possibly through IDO1-potentiated elevation of IL6. Consistent with this hypothesis, mice lacking either IDO1 or IL6 exhibited pulmonary metastasis resistance that was dependent on IFNγ and coupled with reduced tumor neovascularization. Neovascularization in a mouse oxygen-induced retinopathy model was likewise affected by IDO1 or IL6 loss, separating this process from the contextual complexity of the tumor microenvironment. Investigation into the cellular and molecular basis for the observed biology revealed that, within the heterogeneous expanse of Gr1+ MDSCs (myeloid-derived suppressor cells), the ability to independently elicit neovascularization in vivo was restricted to a highly autofluorescent population of CD11blo cells. This included a discrete, IDO1-expressing subpopulation, designated IDVCs (IDO1-dependent vascularizing cells), that, in an IDO1-dependent fashion, dominantly determined whether neovascularization was sustained. Mechanistically, the induction of IDO1 in IDVCs was found to provide a negative feedback constraint on the anti-angiogenic effect of host IFNγ through GCN2 (general control nonderepressible 2)-mediated activation of the integrated stress response and potentiation of IL6 production within these cells. These findings reveal fundamental molecular and cellular insights into how IDO1 interfaces with the inflammatory milieu to support neovascularization. Citation Format: Souvik Dey, Arpita Mondal, James B. DuHadaway, Erika Sutanto-Ward, Lisa Laury-Kleintop, Sunil Thomas, George C. Prendergast, Laura Mandik-Nayak, Alexander J. Muller. IDO1 signaling supports inflammatory neovascularization [abstract]. In: Proceedings of the Annual Meeting of the American Association for Cancer Research 2020; 2020 Apr 27-28 and Jun 22-24. Philadelphia (PA): AACR; Cancer Res 2020;80(16 Suppl):Abstract nr 1474." @default.
• W3082644037 created "2020-09-08" @default.
• W3082644037 creator A5026504972 @default.
• W3082644037 creator A5033586111 @default.
• W3082644037 creator A5059216200 @default.
• W3082644037 creator A5063480688 @default.
• W3082644037 creator A5066825590 @default.
• W3082644037 creator A5075191661 @default.
• W3082644037 creator A5083730849 @default.
• W3082644037 creator A5087182533 @default.
• W3082644037 creator A5089381889 @default.
• W3082644037 date "2020-08-13" @default.
• W3082644037 modified "2023-10-16" @default.
• W3082644037 title "Abstract 1474: IDO1 signaling supports inflammatory neovascularization" @default.
• W3082644037 doi "https://doi.org/10.1158/1538-7445.am2020-1474" @default.
• W3082644037 hasPublicationYear "2020" @default.
• W3082644037 type Work @default.
• W3082644037 sameAs 3082644037 @default.
• W3082644037 citedByCount "0" @default.
• W3082644037 crossrefType "proceedings-article" @default.
• W3082644037 hasAuthorship W3082644037A5026504972 @default.
• W3082644037 hasAuthorship W3082644037A5033586111 @default.
• W3082644037 hasAuthorship W3082644037A5059216200 @default.
• W3082644037 hasAuthorship W3082644037A5063480688 @default.
• W3082644037 hasAuthorship W3082644037A5066825590 @default.
• W3082644037 hasAuthorship W3082644037A5075191661 @default.
• W3082644037 hasAuthorship W3082644037A5083730849 @default.
• W3082644037 hasAuthorship W3082644037A5087182533 @default.
• W3082644037 hasAuthorship W3082644037A5089381889 @default.
• W3082644037 hasBestOaLocation W30826440371 @default.
• W3082644037 hasConcept C2778271429 @default.
• W3082644037 hasConcept C2780394083 @default.
• W3082644037 hasConcept C41008148 @default.
• W3082644037 hasConcept C502942594 @default.
• W3082644037 hasConcept C71924100 @default.
• W3082644037 hasConceptScore W3082644037C2778271429 @default.
• W3082644037 hasConceptScore W3082644037C2780394083 @default.
• W3082644037 hasConceptScore W3082644037C41008148 @default.
• W3082644037 hasConceptScore W3082644037C502942594 @default.
• W3082644037 hasConceptScore W3082644037C71924100 @default.
• W3082644037 hasLocation W30826440371 @default.
• W3082644037 hasOpenAccess W3082644037 @default.
• W3082644037 hasPrimaryLocation W30826440371 @default.
• W3082644037 hasRelatedWork W1506200166 @default.
• W3082644037 hasRelatedWork W1995515455 @default.
• W3082644037 hasRelatedWork W2039318446 @default.
• W3082644037 hasRelatedWork W2048182022 @default.
• W3082644037 hasRelatedWork W2080531066 @default.
• W3082644037 hasRelatedWork W2604872355 @default.
• W3082644037 hasRelatedWork W2748952813 @default.
• W3082644037 hasRelatedWork W2899084033 @default.
• W3082644037 hasRelatedWork W3032375762 @default.
• W3082644037 hasRelatedWork W3108674512 @default.
• W3082644037 isParatext "false" @default.
• W3082644037 isRetracted "false" @default.
• W3082644037 magId "3082644037" @default.
• W3082644037 workType "article" @default.